Please ensure Javascript is enabled for purposes of website accessibility

AstraZeneca

Apr 27, 2012

Jallal named to UM Health Sciences Research Park board

Bahija Jallal, Ph.D., executive vice president of research and development at MedImmune, has been named to the board of directors of the UM Health Sciences Research Park Corp. Jallal is […]

Oct 10, 2011

Speaking fees declining for pharmaceutical firms

The amount of money paid by pharmaceutical firms to physicians and other health professionals to speak about their products seems to be slowing, but a look at 12 companies that […]

Feb 16, 2011

PDL will pay Gaithersburg-based MedImmune $92.5M in patent settlement

NEW YORK — PDL BioPharma Inc. said Wednesday it will pay a total of $92.5 million to settle a patent dispute with AstraZeneca PLC’s MedImmune unit, and added that MedImmune […]

Networking Calendar

Submit an entry for the business calendar